Please sign in to follow a disease.
Which spacer works best for wheezing tots? new study has answers
NCT ID NCT03900494
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different spacer devices (valved holding chambers) used to give asthma medicine to children aged 6 months to 4 years with sudden wheezing. 80 children from Finnish hospitals took part. The goal was to see if one spacer worked better for symptom relief, hospital stays, and side effects. The results help doctors choose the best device for treating breathing trouble in young kids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Apr 2019
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 months to 4 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Children (age 0.5-4 years) seeking medical aid due to respiratory distress caused by bronchial obstruction Exclusion Criteria: * requiring immediate admission to inpatient treatment in hospital * peripheral capillary oxygen saturation below 85% on admission * physician-confirmed pneumonia * inspiratory crackles on lung auscultation * croup * airway foreign body * impaired renal or liver function * immune compromised patient * general condition affecting the study per investigation judgement * bronchopulmonary dysplasia * long-acting beta-adrenoceptor agonist treatment * recruited to the ongoing study earlier * have been enrolled in a clinical trial within 30 days prior to admission * not willing to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchial obstruction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kuopio University Hospital
Kuopio, 70210, Finland
-
Oulu University Hospital
Oulu, 90220, Finland
-
Tampere University Hospital
Tampere, 33521, Finland
-
Terveystalo Tampere
Tampere, 33100, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.